Literature DB >> 10886334

Polysorbate-80 coating enhances uptake of polybutylcyanoacrylate (PBCA)-nanoparticles by human and bovine primary brain capillary endothelial cells.

P Ramge1, R E Unger, J B Oltrogge, D Zenker, D Begley, J Kreuter, H Von Briesen.   

Abstract

Certain drugs such as dalargin, loperamide or tubocurarine are not transported across the blood-brain barrier (BBB) and therefore exhibit no effects on the central nervous system. However, effects on the central nervous system can be observed when these drugs are loaded onto polybutylcyanoacrylate (PBCA)-nanoparticles and coated with polysorbate 80. The mechanism by which these complexed nanoparticles cross the BBB and exhibit their effects has not been elucidated. Cultured microvessel brain endothelial cells of human and bovine origin were used as an in vitro model for the BBB to gain further insight into the mechanism of uptake of nanoparticles. With cells from these species we were able to show that polysorbate 80-coated nanoparticles were taken up by brain endothelial cells much more rapidly and in significantly higher amounts (20-fold) than uncoated nanoparticles. The process of uptake was followed by fluorescence and confocal laser scanning microscopy. The results demonstrate that the nanoparticles are taken up by cells and that this uptake occurs via an endocytotic mechanism.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10886334     DOI: 10.1046/j.1460-9568.2000.00078.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  30 in total

Review 1.  Nanoparticulate systems for growth factor delivery.

Authors:  Sufeng Zhang; Hasan Uludağ
Journal:  Pharm Res       Date:  2009-05-05       Impact factor: 4.200

Review 2.  Biomaterials for the central nervous system.

Authors:  Yinghui Zhong; Ravi V Bellamkonda
Journal:  J R Soc Interface       Date:  2008-09-06       Impact factor: 4.118

3.  Self-assembled biodegradable nanoparticles developed by direct dialysis for the delivery of paclitaxel.

Authors:  Jingwei Xie; Chi-Hwa Wang
Journal:  Pharm Res       Date:  2005-09-03       Impact factor: 4.200

Review 4.  Nanomedicine in Central Nervous System (CNS) Disorders: A Present and Future Prospective.

Authors:  Shringika Soni; Rakesh Kumar Ruhela; Bikash Medhi
Journal:  Adv Pharm Bull       Date:  2016-09-25

Review 5.  Role of metal dyshomeostasis in Alzheimer's disease.

Authors:  David J Bonda; Hyoung-gon Lee; Jeffrey A Blair; Xiongwei Zhu; George Perry; Mark A Smith
Journal:  Metallomics       Date:  2011-02-07       Impact factor: 4.526

6.  Direct evidence that polysorbate-80-coated poly(butylcyanoacrylate) nanoparticles deliver drugs to the CNS via specific mechanisms requiring prior binding of drug to the nanoparticles.

Authors:  Jörg Kreuter; Peter Ramge; Valery Petrov; Stefan Hamm; Svetlana E Gelperina; Britta Engelhardt; Renad Alyautdin; Hagen von Briesen; David J Begley
Journal:  Pharm Res       Date:  2003-03       Impact factor: 4.200

7.  Novel method to label solid lipid nanoparticles with 64cu for positron emission tomography imaging.

Authors:  Erica Andreozzi; Jai Woong Seo; Katherine Ferrara; Angelique Louie
Journal:  Bioconjug Chem       Date:  2011-03-09       Impact factor: 4.774

8.  Poly (n-butyl cyanoacrylate) as a nanocarrier for rivastigmine transport across the blood-brain barrier in Alzheimer's disease treatment: a perspective from molecular dynamics simulations.

Authors:  Seyed Vahid Mousavi; Seyed Majid Hashemianzadeh
Journal:  J Mol Model       Date:  2018-08-25       Impact factor: 1.810

Review 9.  Novel treatment strategies for brain tumors and metastases.

Authors:  Salma E El-Habashy; Alaa M Nazief; Chris E Adkins; Ming Ming Wen; Amal H El-Kamel; Ahmed M Hamdan; Amira S Hanafy; Tori O Terrell; Afroz S Mohammad; Paul R Lockman; Mohamed Ismail Nounou
Journal:  Pharm Pat Anal       Date:  2014-05

10.  Longitudinal monitoring of microglial/macrophage activation in ischemic rat brain using Iba-1-specific nanoparticle-enhanced magnetic resonance imaging.

Authors:  Laurel O Sillerud; Yirong Yang; Lisa Y Yang; Kelsey B Duval; Jeffrey Thompson; Yi Yang
Journal:  J Cereb Blood Flow Metab       Date:  2020-09-22       Impact factor: 6.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.